A

Aker Biomarine ASA
OSE:AKBM

Watchlist Manager
Aker Biomarine ASA
OSE:AKBM
Watchlist
Price: 102 NOK -1.35%
Market Cap: kr8.9B

Gross Margin

45.7%
Current
Improving
by 8.2%
vs 3-y average of 37.4%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
45.7%
=
Gross Profit
$121.3m
/
Revenue
$265.7m

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
45.7%
=
Gross Profit
kr121.3m
/
Revenue
$265.7m

Peer Comparison

Country Company Market Cap Gross
Margin
NO
Aker Biomarine ASA
OSE:AKBM
8.9B NOK
Loading...
JP
Goyo Foods Industry Co Ltd
TSE:2230
53.2T JPY
Loading...
CH
Nestle SA
SIX:NESN
205.1B CHF
Loading...
US
Mondelez International Inc
NASDAQ:MDLZ
75.4B USD
Loading...
FR
Danone SA
PAR:BN
47B EUR
Loading...
ZA
Tiger Brands Ltd
JSE:TBS
55.3B ZAR
Loading...
US
Hershey Co
NYSE:HSY
45B USD
Loading...
ZA
Avi Ltd
JSE:AVI
38B ZAR
Loading...
CH
Chocoladefabriken Lindt & Spruengli AG
SIX:LISN
29.2B CHF
Loading...
CN
Muyuan Foods Co Ltd
SZSE:002714
247.7B CNY
Loading...
CN
Foshan Haitian Flavouring and Food Co Ltd
SSE:603288
208.6B CNY
Loading...

Market Distribution

In line with most companies in Norway
Percentile
57th
Based on 655 companies
57th percentile
45.7%
Low
-3 145.8% — 7.6%
Typical Range
7.6% — 59.8%
High
59.8% — 1 122%
Distribution Statistics
Norway
Min -3 145.8%
30th Percentile 7.6%
Median 38.1%
70th Percentile 59.8%
Max 1 122%

Aker Biomarine ASA
Glance View

Market Cap
8.9B NOK
Industry
Food Products

Aker BioMarine AS operates as a biotech innovator and Antarctic krill-harvesting company which develops krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. The company is headquartered in Lysaker, Akershus. The company went IPO on 2020-07-06. The company consists of two business segments: Ingredients and Brands. Under The Ingredients segment, the Company develops krillbased ingredients for human applications in the nutraceutical and dietary supplement space, and animal feed applications for aquaculture and pet food. Under The Brands segment, the Company has two companies: Lang Pharma Nutrition and Epion Brands. Lang Pharma Nutrition is a full service, mass market private label and corporate brand manufacturer within supplements. Epion Brands has its own consumer brand in the US market, Kori, being on the shelves of retailers. Aker BioMarine’s focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste.

AKBM Intrinsic Value
37.07 NOK
Overvaluation 64%
Intrinsic Value
Price
A
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
45.7%
=
Gross Profit
$121.3m
/
Revenue
$265.7m
What is Aker Biomarine ASA's current Gross Margin?

The current Gross Margin for Aker Biomarine ASA is 45.7%, which is above its 3-year median of 37.4%.

How has Gross Margin changed over time?

Over the last 3 years, Aker Biomarine ASA’s Gross Margin has increased from 37.5% to 45.7%. During this period, it reached a low of 31.1% on Sep 30, 2024 and a high of 45.7% on Sep 30, 2025.

Back to Top